Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：4.4 Date：2025-06-16

Frontiers in Pharmacology

Xanthohumol ameliorates diabetic kidney disease through suppression of renal fibrosis by regulating SNHG10/miR-378b

Products： ELK1156、 ELK1157、 ELK1190、 ELK1270、 ELK1271、 ELK1387
IF：4.4 Date：2025-06-16

Frontiers in Pharmacology

Pathogenesis-directed therapy of methylphenidate-induced oxidative heart damage in rats

Products： ELK5986
IF：4.6 Date：2025-06-16

Inflammopharmacology

Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer’s disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress

Products： ELK10643
IF：4.6 Date：2025-06-16

Frontiers in Cellular and Infection Microbiology

Helicobacter pylori induced miR-362-5p upregulation drives gastric cancer progression and links hepatocellular carcinoma through an exosome-dependent pathway

Products： ES4255

< Page of 308 >